Oct 16, 2023 | Cost Savings, MedBen Rx, Pharmacies, Prescription drugs, Rx Costs, Savings
From a new report published by the U.S. Department of Health & Human Services: “Over the period from January 2022 to January 2023, more than 4,200 drug products had price increases, of which 46 percent were larger than the rate of inflation. The average drug...
Sep 5, 2023 | Access solutions, MedBen Rx, Reporting, Rx Costs, Savings, Specialty Drugs, Surveys
A new survey by International Foundation of Employee Benefit Plans found employers expect plan costs to increase seven percent in 2024. As to why, they gave a range of answers, with the top four reasons representing 71 percent of responses (see chart below). As it...
Aug 7, 2023 | Access solutions, Case Study, Limited Use HRA, MedBen Rx, Patient advocacy program, Prescription drugs, Rx Costs, Rx prices, Rx Spending, Savings, Specialty Drugs
With specialty drugs now making up about half of total drug spending – and poised to go even higher as more new specialty drugs roll out every year – the need for workable access solutions grows. Fortunately, MedBen Rx has them. Our unique approach incorporates a...
Jul 11, 2023 | Brand Name Drugs, Generic Drugs, MedBen Rx, Pharmacies, Pharmacy Benefits Manager (PBM), Prescription drugs, Rx Costs, Rx prices, Rx Spending, Savings, Specialty Drugs, Transparency, Value
A new playbook from the National Alliance of Healthcare Purchaser Coalitions lists the top 10 concerns employer health plans have with pharmacy benefit managers (PBMs): Promoting drugs with higher prices when lower-price options are availableOffering preferred...
May 16, 2023 | Access solutions, Announcements, Client Report, Cost Plus, MedBen, MedBen Rx, Mobile app, Online Services, Prescription drugs, Rx Costs, Rx prices, Rx Spending, Savings, Specialty Drugs
The 2023 MedBen Client Report is now available to download from MedBen.com! In his opening note, MedBen President Kurt Harden states: “This Client Report is designed to demonstrate ways that clients can generate greater value from their health plan....
Mar 21, 2023 | Brand Name Drugs, Diabetes, Generic Drugs, MedBen Rx, MedBen University, Pharmacy Benefits Manager (PBM), Prescription drugs, Rx Costs, Rx prices, Savings
Earlier this month, drug manufacturer Eli Lilly announced that it cutting the cost of two of its prescription brand insulins, Humalog and Humulin, by 70%, and capping out-of-pocket costs for privately insured patients at $35 a month. Competing...
